Iovate Health Sciences, Inc. (“Iovate”) and the University of Florida Research Foundation, Inc. (the “Foundation”) appeal from the summary judgment order of the United States District Court for the Eastern District of Texas holding claims 1, 2, 5, 7, 8, 9, and 18 of U.S. Patent 6,100,287 (“the ’287 patent”) invalid as anticipated under 35 U.S.C. § 102(b). Iovate Health Sciences, Inc. v. Bio-Engineered Supplements & Nutrition, Inc., No. 9:07-CV-46 (E.D. Tex. Aug. 27, 2008) (“Summary Judgment Order”). Because the invention claimed in the ’287 patent was disclosed in a printed publication before the critical date, we affirm the district court’s decision.
Download Iovate Health Sci., Inc. v. Bio-Engineered Supplements & Nutrition, Inc.
